URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Scott McNitt

Concepts (322)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Defibrillators, Implantable
61
2004
418
6.670
Why?
Death, Sudden, Cardiac
38
2004
294
4.260
Why?
Long QT Syndrome
33
2005
387
4.070
Why?
Heart Failure
30
2004
367
3.610
Why?
Cardiac Resynchronization Therapy
18
2010
89
3.130
Why?
Ventricular Dysfunction, Left
25
2004
164
2.930
Why?
Myocardial Infarction
29
2005
660
2.830
Why?
Tachycardia, Ventricular
19
2004
156
2.430
Why?
Electrocardiography
38
2005
773
2.290
Why?
Proportional Hazards Models
38
2004
450
1.780
Why?
KCNQ1 Potassium Channel
9
2007
76
1.680
Why?
Ventricular Fibrillation
13
2004
96
1.590
Why?
Heart Arrest
16
2004
153
1.560
Why?
Risk Assessment
36
2004
884
1.540
Why?
Romano-Ward Syndrome
7
2007
37
1.520
Why?
Ether-A-Go-Go Potassium Channels
9
2006
56
1.520
Why?
Risk Factors
56
2004
2345
1.510
Why?
Male
114
1980
19675
1.480
Why?
Female
112
2004
19838
1.450
Why?
Adrenergic beta-Antagonists
18
2005
174
1.370
Why?
Mutation
12
2006
1216
1.280
Why?
Aged
67
2004
7269
1.280
Why?
Heart Conduction System
10
2004
153
1.230
Why?
Middle Aged
68
2004
9837
1.230
Why?
Treatment Outcome
41
2004
2615
1.210
Why?
Electric Countershock
10
2004
95
1.190
Why?
Heart Rate
14
2005
461
1.160
Why?
Atrial Fibrillation
7
2006
110
1.120
Why?
Humans
119
1978
36274
1.100
Why?
Syncope
12
2006
115
0.980
Why?
Kaplan-Meier Estimate
20
2007
222
0.960
Why?
Arrhythmias, Cardiac
9
2004
246
0.920
Why?
Stroke Volume
14
2005
154
0.900
Why?
Genotype
17
2007
490
0.870
Why?
Cardiomyopathies
6
2010
82
0.870
Why?
European Continental Ancestry Group
5
2006
234
0.820
Why?
Follow-Up Studies
29
2004
1855
0.820
Why?
Adult
43
2005
11351
0.800
Why?
Genetic Predisposition to Disease
12
2006
331
0.780
Why?
Myocardial Ischemia
8
2005
118
0.770
Why?
Survival Analysis
21
2004
606
0.730
Why?
Cause of Death
9
2004
162
0.730
Why?
African Continental Ancestry Group
3
2006
125
0.700
Why?
Young Adult
15
2008
1059
0.680
Why?
Arrhythmogenic Right Ventricular Dysplasia
1
2009
20
0.660
Why?
Hemostasis, Surgical
1
2008
12
0.660
Why?
Punctures
1
2008
24
0.660
Why?
Coagulants
1
2008
13
0.650
Why?
Survival Rate
18
2005
618
0.650
Why?
Ventricular Function, Left
4
2011
95
0.640
Why?
Femoral Artery
1
2008
80
0.630
Why?
Angioplasty, Balloon, Coronary
1
2008
66
0.630
Why?
Mutation, Missense
4
2007
87
0.630
Why?
Adolescent
23
2005
4766
0.620
Why?
Electrocardiography, Ambulatory
6
2007
93
0.610
Why?
Echocardiography
11
2007
228
0.590
Why?
Registries
13
2006
223
0.590
Why?
Chi-Square Distribution
12
2006
344
0.590
Why?
Time Factors
20
2004
3182
0.590
Why?
Prospective Studies
15
2005
1689
0.590
Why?
Prognosis
18
2004
1083
0.580
Why?
Hemorrhage
1
2008
180
0.570
Why?
Retrospective Studies
18
2004
2267
0.560
Why?
Child
17
2006
4155
0.530
Why?
Heart Diseases
1
2006
142
0.520
Why?
Multivariate Analysis
13
2008
541
0.520
Why?
Phenotype
9
2006
763
0.500
Why?
Incidence
11
2006
685
0.480
Why?
Ventricular Remodeling
4
2010
38
0.470
Why?
Recurrence
9
2006
691
0.460
Why?
Child, Preschool
14
2006
2660
0.450
Why?
Infant
13
2006
2278
0.450
Why?
Myocardial Contraction
3
2011
111
0.430
Why?
Heart
3
2010
236
0.390
Why?
Aza Compounds
4
2006
23
0.380
Why?
Sex Factors
10
2005
597
0.380
Why?
Quinolines
4
2006
44
0.370
Why?
Smoking
3
2006
399
0.370
Why?
Sodium Channels
3
2008
120
0.360
Why?
Jervell-Lange Nielsen Syndrome
2
2006
11
0.340
Why?
Diabetes Mellitus
2
2009
169
0.340
Why?
Myocardial Revascularization
2
2006
22
0.330
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2006
48
0.330
Why?
United States
8
2005
2688
0.320
Why?
Infant, Newborn
8
2007
1844
0.320
Why?
Catheter Ablation
2
2009
73
0.320
Why?
Sequence Deletion
2
2007
129
0.310
Why?
Muscle Proteins
2
2008
142
0.310
Why?
Polymorphism, Genetic
3
2006
201
0.310
Why?
Codon, Nonsense
2
2007
56
0.310
Why?
Severity of Illness Index
9
2005
922
0.300
Why?
Membrane Potentials
2
2007
340
0.300
Why?
Cardiovascular Diseases
4
2004
277
0.290
Why?
Anti-Arrhythmia Agents
2
2006
77
0.280
Why?
Models, Molecular
2
2007
355
0.280
Why?
DNA
2
2011
845
0.270
Why?
Logistic Models
6
2004
611
0.270
Why?
Anti-Infective Agents
4
2006
75
0.270
Why?
Predictive Value of Tests
7
2005
606
0.260
Why?
Cohort Studies
9
2004
969
0.250
Why?
Statistics, Nonparametric
6
2004
262
0.240
Why?
Age Distribution
6
2007
221
0.240
Why?
Ventricular Premature Complexes
2
2008
18
0.240
Why?
Ion Channels
2
2010
153
0.230
Why?
Multicenter Studies as Topic
4
2004
129
0.230
Why?
Smoking Cessation
2
2006
80
0.220
Why?
Aged, 80 and over
9
2006
2529
0.220
Why?
Ventricular Dysfunction, Right
2
2009
18
0.220
Why?
Canada
2
2009
75
0.220
Why?
Tobacco Use Cessation Products
1
2012
3
0.210
Why?
Acute Coronary Syndrome
1
2012
10
0.210
Why?
Age Factors
6
2006
1128
0.210
Why?
Sex Distribution
5
2007
160
0.210
Why?
Torsades de Pointes
2
2008
32
0.200
Why?
Diabetic Angiopathies
1
2012
34
0.200
Why?
Odds Ratio
5
2004
315
0.200
Why?
Risk
5
2004
368
0.200
Why?
Coronary Care Units
1
2011
18
0.200
Why?
Heart-Assist Devices
1
2011
34
0.200
Why?
Cardiomyopathy, Dilated
1
2011
42
0.200
Why?
Angiotensin-Converting Enzyme Inhibitors
2
2006
48
0.200
Why?
Randomized Controlled Trials as Topic
4
2004
411
0.190
Why?
Cardiac Pacing, Artificial
2
2010
158
0.190
Why?
Cardiac Resynchronization Therapy Devices
1
2011
13
0.190
Why?
Menopause
1
2011
43
0.190
Why?
Age of Onset
2
2007
126
0.190
Why?
Heterozygote
2
2007
125
0.190
Why?
Patient Admission
1
2011
85
0.190
Why?
Heart Block
1
2011
57
0.190
Why?
Electrodes, Implanted
1
2011
57
0.190
Why?
Ambulatory Care
1
2011
156
0.180
Why?
Hypothermia, Induced
1
2010
29
0.180
Why?
Autonomic Nervous System
1
2010
68
0.180
Why?
Diagnosis, Computer-Assisted
2
2007
62
0.180
Why?
Electrophysiologic Techniques, Cardiac
2
2005
24
0.180
Why?
Polymorphism, Single Nucleotide
2
2007
90
0.180
Why?
Death
1
2010
23
0.180
Why?
Delayed Rectifier Potassium Channels
2
2006
10
0.180
Why?
Cardiomegaly
1
2010
44
0.180
Why?
Heart Atria
1
2010
68
0.170
Why?
Protein Structure, Secondary
1
2009
86
0.170
Why?
Ventricular Function, Right
2
2005
26
0.170
Why?
Ion Channel Gating
1
2011
127
0.170
Why?
Coronary Artery Bypass
1
2010
106
0.170
Why?
Glomerular Filtration Rate
2
2006
88
0.170
Why?
Cardiology
1
2010
54
0.170
Why?
Early Ambulation
1
2008
5
0.170
Why?
Angiography
1
2009
93
0.170
Why?
Ventricular Dysfunction
1
2008
7
0.160
Why?
Body Mass Index
1
2010
218
0.160
Why?
Sotalol
1
2008
16
0.160
Why?
Models, Biological
2
2011
1008
0.160
Why?
Conserved Sequence
1
2009
103
0.160
Why?
Acetanilides
1
2008
9
0.160
Why?
Administration, Topical
1
2008
89
0.160
Why?
Pressure
1
2008
130
0.160
Why?
Adrenergic beta-Agonists
1
2008
51
0.160
Why?
Asian Continental Ancestry Group
1
2008
30
0.160
Why?
Tachycardia, Supraventricular
1
2008
19
0.160
Why?
Siblings
1
2008
36
0.160
Why?
Atrial Flutter
1
2008
25
0.160
Why?
Physicians
1
2010
157
0.150
Why?
New York
5
2005
1305
0.150
Why?
Medical History Taking
1
2008
62
0.150
Why?
Piperazines
1
2008
74
0.150
Why?
Genetic Variation
1
2008
151
0.150
Why?
Cholesterol Ester Transfer Proteins
1
2007
15
0.150
Why?
Frameshift Mutation
1
2007
22
0.150
Why?
Japan
1
2007
30
0.150
Why?
African Americans
1
2010
219
0.150
Why?
RNA Splice Sites
1
2007
17
0.150
Why?
Netherlands
1
2007
29
0.150
Why?
Aryldialkylphosphatase
1
2007
6
0.150
Why?
Sodium
1
2008
298
0.150
Why?
Pregnancy, High-Risk
1
2007
14
0.150
Why?
Coronary Artery Disease
1
2008
96
0.150
Why?
Mutagenesis, Insertional
1
2007
53
0.150
Why?
Ion Transport
1
2007
70
0.150
Why?
Pregnancy Complications, Cardiovascular
1
2007
38
0.140
Why?
Probability
4
2004
302
0.140
Why?
Kidney
1
2010
586
0.140
Why?
Primary Prevention
1
2007
58
0.140
Why?
Hospitalization
5
2004
399
0.140
Why?
Angiotensinogen
1
2006
8
0.140
Why?
Physician's Practice Patterns
1
2010
243
0.140
Why?
Nitric Oxide Synthase Type III
1
2007
66
0.140
Why?
Bundle-Branch Block
3
2011
51
0.140
Why?
Attitude of Health Personnel
1
2010
289
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2010
267
0.140
Why?
Protein Transport
1
2007
168
0.140
Why?
Mental Health
1
2007
83
0.140
Why?
Confidence Intervals
3
2007
165
0.140
Why?
Potassium
1
2007
304
0.130
Why?
Flecainide
1
2005
12
0.130
Why?
Pregnancy Outcome
1
2007
137
0.130
Why?
Kidney Failure, Chronic
1
2007
122
0.130
Why?
Protein Structure, Tertiary
1
2007
347
0.130
Why?
Tachycardia
1
2005
67
0.130
Why?
Diabetes Complications
1
2005
66
0.130
Why?
Blood Pressure
1
2007
467
0.120
Why?
Asthma
1
2008
317
0.120
Why?
Obesity
1
2007
339
0.110
Why?
Hypertension
1
2006
301
0.110
Why?
Spain
2
2012
19
0.110
Why?
Minnesota
2
2010
27
0.100
Why?
Echocardiography, Doppler
2
2011
53
0.100
Why?
Europe
2
2011
80
0.100
Why?
Sensitivity and Specificity
3
2006
905
0.100
Why?
World Health
2
2011
63
0.090
Why?
Systole
2
2009
39
0.090
Why?
Exercise
2
2010
182
0.080
Why?
Hospital Mortality
2
2008
137
0.080
Why?
Equipment Failure
2
2008
72
0.080
Why?
Blood Urea Nitrogen
2
2005
43
0.080
Why?
Clinical Trials as Topic
3
2004
671
0.080
Why?
Electrophysiology
2
2005
247
0.080
Why?
Analysis of Variance
2
2007
736
0.070
Why?
Regression Analysis
2
2007
527
0.070
Why?
Reproducibility of Results
2
2007
877
0.070
Why?
Pacemaker, Artificial
2
2008
162
0.070
Why?
Life Tables
2
2004
39
0.070
Why?
Disease Progression
2
2004
521
0.060
Why?
Algorithms
2
2007
541
0.060
Why?
Heart Function Tests
1
2012
33
0.050
Why?
Confounding Factors (Epidemiology)
1
2012
61
0.050
Why?
Precipitating Factors
1
2011
6
0.050
Why?
Disease-Free Survival
1
2012
198
0.050
Why?
Prosthesis Design
1
2011
68
0.050
Why?
Electric Conductivity
1
2011
88
0.050
Why?
Israel
1
2011
38
0.050
Why?
Estrogen Replacement Therapy
1
2011
21
0.050
Why?
Cardiotoxins
1
2011
3
0.050
Why?
Sleep
1
2011
59
0.050
Why?
Neuromuscular Nondepolarizing Agents
1
2011
14
0.050
Why?
Amino Acid Substitution
1
2011
124
0.050
Why?
Drug Evaluation, Preclinical
1
2011
76
0.050
Why?
Blood Volume
1
2010
53
0.050
Why?
Monitoring, Physiologic
1
2010
100
0.050
Why?
Arousal
1
2010
56
0.050
Why?
Blood Circulation
1
2010
38
0.050
Why?
DNA Mutational Analysis
1
2011
189
0.050
Why?
Creatinine
1
2010
127
0.050
Why?
Exercise Test
1
2010
101
0.050
Why?
Guidelines as Topic
1
2011
89
0.050
Why?
Case-Control Studies
1
2012
617
0.040
Why?
Oocytes
1
2011
135
0.040
Why?
Family
1
2011
201
0.040
Why?
Echocardiography, Transesophageal
1
2010
52
0.040
Why?
Xenopus laevis
1
2011
167
0.040
Why?
Heart Ventricles
1
2011
207
0.040
Why?
Organ Size
1
2010
192
0.040
Why?
Obesity, Morbid
1
2010
50
0.040
Why?
Drug Therapy, Combination
2
1978
382
0.040
Why?
Guideline Adherence
1
2010
83
0.040
Why?
Computer Simulation
1
2011
302
0.040
Why?
Kidney Diseases
1
2011
170
0.040
Why?
Health Care Surveys
1
2010
161
0.040
Why?
Continental Population Groups
1
2010
121
0.040
Why?
Physicians, Family
1
2010
109
0.040
Why?
Computational Biology
1
2009
67
0.040
Why?
Patient Selection
1
2010
212
0.040
Why?
Referral and Consultation
1
2010
196
0.040
Why?
Angina Pectoris
1
2008
49
0.040
Why?
Discriminant Analysis
1
2007
22
0.040
Why?
Point Mutation
1
2008
172
0.040
Why?
Postpartum Period
1
2007
38
0.040
Why?
Lipids
1
2007
168
0.040
Why?
Combined Modality Therapy
1
2008
486
0.040
Why?
Practice Guidelines as Topic
1
2010
302
0.040
Why?
Glutamine
1
2007
63
0.040
Why?
Aspartic Acid
1
2007
46
0.040
Why?
Parity
1
2007
49
0.040
Why?
Arginine
1
2007
108
0.040
Why?
Threonine
1
2006
29
0.040
Why?
Methionine
1
2006
52
0.040
Why?
Gene Frequency
1
2006
88
0.040
Why?
Homozygote
1
2006
97
0.030
Why?
Glutamic Acid
1
2007
97
0.030
Why?
Enzyme Inhibitors
1
2008
422
0.030
Why?
ROC Curve
1
2006
126
0.030
Why?
Models, Cardiovascular
1
2006
70
0.030
Why?
Nebraska
1
2005
6
0.030
Why?
Propanolamines
1
2005
11
0.030
Why?
Metoprolol
1
2005
10
0.030
Why?
Atenolol
1
2005
13
0.030
Why?
Gestational Age
1
2007
339
0.030
Why?
Placebo Effect
1
2005
35
0.030
Why?
Biological Markers
1
2008
560
0.030
Why?
Carbazoles
1
2005
28
0.030
Why?
Tomography, X-Ray Computed
1
2010
759
0.030
Why?
Amino Acid Sequence
1
2009
1195
0.030
Why?
Mortality
1
2006
89
0.030
Why?
Placebos
1
2006
178
0.030
Why?
Equipment Failure Analysis
1
2005
71
0.030
Why?
Equipment Design
1
2006
248
0.030
Why?
Outcome Assessment (Health Care)
1
2008
301
0.030
Why?
Survivors
1
2006
118
0.030
Why?
Action Potentials
1
2006
250
0.030
Why?
Prevalence
1
2007
562
0.030
Why?
Research Design
1
2006
336
0.030
Why?
Coronary Disease
1
2006
258
0.030
Why?
Molecular Sequence Data
1
2009
1988
0.030
Why?
Comorbidity
1
2005
380
0.030
Why?
Quality of Life
1
2007
502
0.030
Why?
Double-Blind Method
1
2005
992
0.030
Why?
Pregnancy
1
2007
1966
0.020
Why?
Doxorubicin
2
1978
107
0.020
Why?
Daunorubicin
1
1980
25
0.020
Why?
Neoplasms, Experimental
1
1980
145
0.020
Why?
Leukemia, Lymphoid
1
1978
63
0.020
Why?
Cyclophosphamide
1
1978
174
0.020
Why?
Animals
3
1978
16093
0.020
Why?
Leukemia, Experimental
2
1978
20
0.010
Why?
Melanoma
1
1980
134
0.010
Why?
Cell Survival
1
1980
551
0.000
Why?
DNA, Neoplasm
1
1978
128
0.000
Why?
Mice
2
1978
6111
0.000
Why?
Cell Count
1
1978
286
0.000
Why?
Kinetics
1
1980
1391
0.000
Why?
Drug Administration Schedule
1
1978
366
0.000
Why?
Bone Marrow
1
1978
287
0.000
Why?
Cell Line
1
1980
1585
0.000
Why?

Visualizations


McNitt's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department